周三，Oppenheimer重申了对Jasper Therapeutics (NASDAQ:JSPR)的"优于大市"评级和80.00美元的目标价，此举是在该公司报告了其BEACON研究的初步结果之后。这家市值约18亿美元的临床阶段生物技术公司正在开发用于治疗慢性疾病的创新疗法。

周三，Oppenheimer将iRhythm Technologies (NASDAQ:IRTC)的目标价从之前的105美元上调至120美元，同时重申"跑赢大市"评级。此次调整是在12月底与iRhythm Technologies管理层会面后做出的。iRhythm Technologies是一家市值28亿美元的医疗技术公司。根据 InvestingPro ...

Analysts See Growth at Yum! Brands Units. In naming Yum! Brands one of its top picks, Oppenheimer analysts said that the ...

Oppenheimer raised the firm’s price target on Atlassian (TEAM) to $300 from $270 and keeps an Outperform rating on the shares ...

Today’s tech titans have a chutzpah reminiscent of the scientists behind the atomic bomb.

Oppenheimer put forth eight stocks in the Materials sector, which struggled in 2024, to consider buying, in a strategy to ...

Oppenheimer analyst Kristen Owen maintained a Hold rating on Mosaic Co (MOS – Research Report) today. The company’s shares closed last Friday ...

Oppenheimer analyst Brian Bittner upgraded Cheesecake Factory (CAKE) to Outperform from Perform with a $65 price target The firm said it has ...

格隆汇12月26日｜Oppenheimer策略师John Stoltzfus发布报告表示，回顾2024年，美股韧性惊人，尽管有通胀担忧、利率上升和地缘政治紧张局势不时引发回调，然而这些回调并未破坏整体牛市的格局。Oppenheimer建议投资者在市场下跌时寻找“被错杀的良机”。

Christopher Nolan's next film 'The Odyssey' is a mythic action epic shot across the world using brand new IMAX film ...

Apple / Universal. When Killers Of The Flower Moon first released in theaters and then later on Apple TV, I found the runtime ...

This week on 60 Minutes, Cillian Murphy talks with Scott Pelley about his approach to acting and his preparation for the lead ...